The Consultant & Investment Group (CICO) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

Shareholding (Jun 2023)

FII

0.00%

Held by 0 FIIs

DII

Held by 0 DIIs

Promoter

79.46%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Poor Management Efficiency with a low ROCE of 5.67%

The company has been able to generate a Return on Capital Employed (avg) of 5.67% signifying low profitability per unit of total capital (equity and debt)

High Debt Company with a Debt to Equity ratio (avg) at times

Poor long term growth as Net Sales has grown by an annual rate of 10.47% and Operating profit at 32.67% over the last 5 years

Flat results in Mar 25

With ROE of 8.17%, it has a very expensive valuation with a 1.46 Price to Book Value

Mojo Parameters

Stock DNA

Industry

Miscellaneous Commercial Services

Market cap

JOD 36 Million (Small Cap)

P/E

18.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.23

Return on Equity

8.34%

Price to Book

1.47

Revenue and Profits:

Net Sales:

6 Million

(Quarterly Results - Mar 2025)

Net Profit:

0 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

6.47%

6 Months

6.47%

1 Year

-3.72%

2 Years

-11.71%

3 Years

-2.16%

4 Years

48.36%

5 Years

30.22%

The Consultant & Investment Group for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

10.47%

EBIT Growth (5y)

32.67%

EBIT to Interest (avg)

1.31

Debt to EBITDA (avg)

0.80

Net Debt to Equity (avg)

0.22

Sales to Capital Employed (avg)

0.76

Tax Ratio

14.78%

Dividend Payout Ratio

28.69%

Pledged Shares

Institutional Holding

ROCE (avg)

5.67%

ROE (avg)

4.36%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.46

EV to EBIT

14.75

EV to EBITDA

9.26

EV to Capital Employed

1.36

EV to Sales

1.76

PEG Ratio

Dividend Yield

ROCE (Latest)

9.22%

ROE (Latest)

8.17%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

Bearish

Bollinger Bands

Mildly Bullish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Jun 2023

Shareholding Compare (%holding)

Majority shareholders

Strategic Entities

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is -11.11% vs 6.78% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is 0.00% vs -20.00% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5.60",
          "val2": "6.30",
          "chgp": "-11.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.20",
          "val2": "1.00",
          "chgp": "20.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.30",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.40",
          "val2": "0.40",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "125.10%",
          "val2": "88.10%",
          "chgp": "3.70%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 16.58% vs 4.89% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 75.00% vs -11.11% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "22.50",
          "val2": "19.30",
          "chgp": "16.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.00",
          "val2": "3.10",
          "chgp": "29.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.80",
          "val2": "0.40",
          "chgp": "100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.40",
          "val2": "-0.30",
          "chgp": "-33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.40",
          "val2": "0.80",
          "chgp": "75.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "107.40%",
          "val2": "85.50%",
          "chgp": "2.19%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ

Mar'25

Dec'24

Change(%)

Net Sales

5.60

6.30

-11.11%

Operating Profit (PBDIT) excl Other Income

1.20

1.00

20.00%

Interest

0.30

Exceptional Items

-0.00

0.00

Consolidate Net Profit

0.40

Operating Profit Margin (Excl OI)

125.10%

88.10%

3.70%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2025 is -11.11% vs 6.78% in Dec 2024

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2025 is 0.00% vs -20.00% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

22.50

19.30

16.58%

Operating Profit (PBDIT) excl Other Income

4.00

3.10

29.03%

Interest

0.80

0.40

100.00%

Exceptional Items

-0.40

-0.30

-33.33%

Consolidate Net Profit

1.40

0.80

75.00%

Operating Profit Margin (Excl OI)

107.40%

85.50%

2.19%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 16.58% vs 4.89% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 75.00% vs -11.11% in Dec 2023

All Annual Results

Company CV

About The Consultant & Investment Group

The Consultant & Investment Group

Miscellaneous Commercial Services

Consultant and Investment Group Company Psc is a Jordan-based public shareholding company, which is engaged in the healthcare and medical sector. The Company operates through managing and operating healthcare facilities and projects such as hospitals and clinics. Consulting and Investment Company Group PSC manages and operates Istishari Hospital, which is located in Amman, Jordan, and provides diagnostic and treatment options, as well as personalized patient care and service, among other related facilities. Its clinical services include: anesthesia, dental, endocrinology, family medicine, gastroenterology, hepatology, infections and tropical, diseases, neurology, orthopedics, pediatrics and primary care. Its medical services include: inpatient accommodations, intensive care unit, neonatal intensive care unit and operating theaters.

Company Coordinates

Company Details

King Abdullah Gardens Cross, Wadi Saqrah,, P.O.Box 840431, AMMAN None : 11184

Tel: 962 6 5001000

http://www.istisharihospital.com

Registrar Details